Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components - Breakdown of the Company Revenue (Details)

v3.21.2
Balance Sheet Components - Breakdown of the Company Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Concentration Risk [Line Items]        
Revenues $ 101,563 $ 71,691 $ 188,495 $ 160,180
U.S. revenue        
Concentration Risk [Line Items]        
Revenues 79,740 57,817 150,952 126,223
Non-U.S. revenue        
Concentration Risk [Line Items]        
Revenues $ 21,823 $ 13,874 $ 37,543 $ 33,957